Short answer · Medically reviewed summary · Last updated: 2026-05-08
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is a genetic condition typically inherited in an autosomal dominant pattern. While most cases are hereditary, approximately 10-20% of cases may arise from de novo (spontaneous) mutations, meaning the condition occurs in an individual without a prior family history. Is Paroxysmal Kinesigenic Choreathetosis hereditary? Yes, Paroxysmal Kinesigenic Choreathetosis is primarily a hereditary condition.
Is Paroxysmal Kinesigenic Choreathetosis / Dyskinesia hereditary?
Is Paroxysmal Kinesigenic Choreathetosis / Dyskinesia hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is a genetic condition typically inherited in an autosomal dominant pattern. While most cases are hereditary, approximately 10-20% of cases may arise from de novo (spontaneous) mutations, meaning the condition occurs in an individual without a prior family history.
Is Paroxysmal Kinesigenic Choreathetosis hereditary?
Yes, Paroxysmal Kinesigenic Choreathetosis is primarily a hereditary condition. It is most commonly associated with mutations in the PRRT2 gene, which is located on chromosome 16. Because it follows an autosomal dominant inheritance pattern, an individual with a pathogenic PRRT2 mutation has a 50% chance of passing the condition to each of their children.
How do genetic factors influence Paroxysmal Kinesigenic Dyskinesia?
The PRRT2 gene provides instructions for making a protein involved in neurotransmitter release. In families with Paroxysmal Kinesigenic Choreathetosis, a single altered copy of this gene in each cell is sufficient to cause the disorder. It is important to note that the condition exhibits "incomplete penetrance," meaning some individuals who carry the mutation may never experience symptoms, or may present with related conditions like infantile convulsions.
Is genetic testing available for Paroxysmal Kinesigenic Choreathetosis?
Clinical genetic testing is available and is highly recommended to confirm a diagnosis of Paroxysmal Kinesigenic Dyskinesia. Testing typically involves sequencing the PRRT2 gene. Key considerations for families include:
- Diagnostic confirmation: Provides clarity for patients experiencing episodic movement symptoms.
- Family screening: Allows relatives to understand their own risk of developing Paroxysmal Kinesigenic Choreathetosis.
- Reproductive planning: Genetic counseling can help families understand the 50% recurrence risk and discuss options like preimplantation genetic testing (PGT).
- De novo occurrences: If no family history is present, testing can determine if the mutation occurred spontaneously in the affected individual.
Next steps
- Consult a clinical geneticist to discuss whether PRRT2 testing is appropriate for your family.
- Connect with the 7 members of the Paroxysmal Kinesigenic Choreathetosis community at DiseaseMaps.org to share experiences and coping strategies.
- Maintain a detailed symptom log to help your neurologist distinguish Paroxysmal Kinesigenic Dyskinesia from other paroxysmal movement disorders.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional for diagnosis and management.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Paroxysmal Kinesigenic Dyskinesia.
- Orphanet: Paroxysmal kinesigenic choreoathetosis (ORPHA:2546).
- OMIM (Online Mendelian Inheritance in Man): Paroxysmal Kinesigenic Dyskinesia 1 (PKD1; #128200).
- PubMed: Review of PRRT2-associated paroxysmal neurological disorders.
